Chemo for Certain Small, HR+, HER2+ BC Seems to Improve Survival

Moderators

Chemotherapy for Certain Small, Hormone-Receptor-Positive, HER2-Positive Breast Cancers Seems to Improve Survival
May 7, 2020
When looking at treatment outcomes for small, node-negative, hormone-receptor-positive, HER2-positive breast cancers, a study suggests that women diagnosed with cancers 8-10 mm in size had better survival when they were treated with chemotherapy after surgery, compared to women diagnosed with smaller cancers. Read more...